Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 639856 | https://doi.org/10.1155/2014/639856

Karine Rech Begnini, Priscila Marques Moura de Leon, Helena Thurow, Eduarda Schultze, Vinicius Farias Campos, Fernanda Martins Rodrigues, Sibele Borsuk, Odir Antônio Dellagostin, Lucielli Savegnago, Mariana Roesch-Ely, Sidnei Moura, Francine F. Padilha, Tiago Collares, João Antonio Pêgas Henriques, Fabiana Kömmling Seixas, "Brazilian Red Propolis Induces Apoptosis-Like Cell Death and Decreases Migration Potential in Bladder Cancer Cells", Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 639856, 13 pages, 2014. https://doi.org/10.1155/2014/639856

Brazilian Red Propolis Induces Apoptosis-Like Cell Death and Decreases Migration Potential in Bladder Cancer Cells

Academic Editor: Flávia R. F. do Nascimento
Received07 Jul 2014
Accepted06 Oct 2014
Published03 Nov 2014


Natural products continue to be an invaluable resource of anticancer drug discovery in recent years. Propolis is known for its biological activities such as antimicrobial and antitumor effects. This study assessed the effects of Brazilian red propolis (BRP) on apoptosis and migration potential in human bladder cancer cells. The effect of BRP ethanolic extract (25, 50, and 100 μg/mL) on 5637 cells was determined by MTT, LIVE/DEAD, and migration (scratch assay) assays. Apoptosis induction was investigated through flow cytometry and gene expression profile was investigated by qRT-PCR. Results showed cytotoxicity on MTT and LIVE/DEAD assays, with IC50 values of 95 μg/mL in 24 h of treatment. Cellular migration of 5637 cells was significantly inhibited through lower doses of BRP ethanolic extract (25 and 50 μg/mL). Flow cytometry analyses showed that BRP induced cytotoxicity through apoptosis-like mechanisms in 5637 cells and qRT-PCR revealed increased levels of Bax/Bcl-2 ratio, p53, AIF, and antioxidant enzymes genes. Data suggest that BRP may be a potential source of drugs to bladder cancer treatment.

1. Introduction

Cancer is one of the leading causes of death in both developing and developed countries and is a worldwide concern. A total of 1,660,290 new cancer cases and 580,350 cancer deaths are projected to occur in the United States in 2013 [1] and by 2050, 27 million new cancer cases and 17.5 million cancer deaths are projected to occur in the world [2]. An analysis of the anticancer drugs revealed that 47.1% of the approved anticancer drugs were either unmodified natural products or their semisynthetic derivatives or synthesized molecules based on natural product compound pharmacophores [3]. Natural products tend to present more structurally diverse “drug-like” and “biologically friendly” molecular qualities than pure synthetic compounds at random [4] and have been considered as an “unlimited” resource for future drug discovery [5].

Propolis is a resinous mixture of substances collected by honey bees (Apis mellifera) from various plant sources. It has been used in folk medicine for centuries mostly due to its antimicrobial and anti-inflammatory activities [6]. Notable chemical differences are often found between propolis samples and Brazil has the widest chemical diversity of propolis types [7]. Brazilian red propolis (BRP) is the newest variety of Brazilian propolis and is a promising source of new bioactive compounds [8] like chalcones, pterocarpans, isoflavonoids, and polyphenols [9].

Since its discovery, BRP has been studied to elucidate its several biological properties. Studies have shown antitumor properties of red propolis against several types of cancer both in vitro and in vivo [8, 1014]. The mechanisms involved on potential anticancer effects of propolis are suppressing cancer/precancerous cells proliferation via its immunomodulatory effect; decreasing the cancer stem cell populations; blocking specific oncogene signaling pathways; modulating the tumor microenvironment; and, lastly, being an adjunct or complementary treatment to existing mainstream anticancer therapies [15]. Besides that, BRP had also shown a potent antiangiogenic activity by targeting key steps that are required for new blood vessel development [16, 17], showing a natural chemopreventive activity.

The aim of this study was to investigate whether Brazilian red propolis ethanolic extracts have cytotoxic effect and study the underlying cell death mechanisms in human bladder cancer cells.

2. Materials and Methods

2.1. Red Propolis Sample and Extract Preparation

The red propolis was collected from a geographic region on northeast of Brazil known as Brejo Grande (S 10°28′25′′ and W 36°26′12′′). The samples of red propolis were collected in September 2011 and frozen at −20°C. For extract preparation, 1 g (dry weight) of raw red propolis was mixed with 10 mL of EtOH-H2O 70% (v/v) and shaken at room temperature for 24 h. After extraction, the mixture was filtered and the solvent was evaporated and produced a red fine powder. This dry extract was kept frozen at −20°C. The BRP final concentrations (25, 50, and 100 μg/mL) were prepared immediately before use with EtOH-H2O 50% (v/v).

2.2. Chemical Characterization of Red Propolis Extract (Mass Analysis)

The dries extracts were dissolved in a solution of 50% (v/v) chromatographic grade acetonitrile (Tedia, Fairfield, OH, USA), 50% (v/v) deionized water, and 0.1% formic acid. The solutions were infused directly individually into the ESI source by means of a syringe pump (Harvard Apparatus) at a flow rate of 50 μL min−1. ESI(+)-MS and tandem ESI(+)-MS/MS were acquired using a hybrid high-resolution and high accuracy (5 μg/L) microTof (Q-TOF) mass spectrometer (Bruker Scientific) under the following conditions: capillary and cone voltages were set to +3500 V and +40 V, respectively, with a desolvation temperature of 100°C. For ESI(+)-MS/MS, the energy for the collision induced dissociations (CID) was optimized for each component. Diagnostic ions in different fractions were identified by the comparison of their ESI(+)-MS/MS dissociation patterns with compounds identified in previous studies. For data acquisition and processing, compass software (Bruker Scientific) was used. The data were collected in the m/z range of 70–800 at the speed of two scans per second, providing the resolution of 50,000 (FWHM) at m/z 200. No important ions were observed below m/z 180 or above m/z 650; therefore ESI(+)-MS data is shown in the m/z 180−650 range.

2.3. Cell Culture

The human bladder carcinoma cell line (5637) was obtained from the Rio de Janeiro Cell Bank (PABCAM, Federal University of Rio de Janeiro, RJ, Brazil) and cultured as a monolayer in Dulbecco’s modified Eagle’s medium (DMEM) (Vitrocell Embriolife, Campinas, Brazil), supplemented with 10% fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA), 1% L-glutamine, and 1% penicillin/streptomycin. Cells were grown at 37°C in an atmosphere of 95% humidified air and 5% CO2.

2.4. Antiproliferative Assay

The proliferation of the 5637-cell line after treatment was determined by measuring the reduction of soluble MTT to water insoluble formazan. Cells were seeded at a density of 2 × 104 cell per well in a volume of 100 μL in 96-well plates and grown at 37°C in a 5% CO2 atmosphere for 24 h before being used in the cell viability assay. Cells were then treated with the red propolis extract EtOH-H2O 50% (v/v) at concentrations of 25, 50, and 100 μg/mL or EtOH-H2O 50% vehicle alone, for 24 h. Following incubation, 20 μL of MTT was added to each well, and the cells were incubated for an additional 3 hours at 37°C. Differences in total cellular metabolism were detected at a wavelength of 492 nm using a microplater reader. The inhibition (%) of cell proliferation was determined as follows: inhibitory growth = [18]. The IC50 (concentration μg/mL that inhibits 50% of cell growth) was also calculated using GraphPad Prism 5.0 Software. The normal CHO-K1 cell line was used as selectivity control in this test. All observations were validated by at least three independent experiments in triplicate for each experiment.

2.5. LIVE/DEAD Assay

Cells were treated with red propolis extract EtOH-H2O 50% (v/v) at concentrations 25, 50, and 100 μg/mL for 24 h as described above. LIVE/DEAD cell viability assay (Invitrogen, Carlsbad, CA, USA) was conducted following the manufacturer’s instructions. Live cells were able to take up calcein and could be analyzed by green fluorescent light emission (488 nm). Ethidium bromide homodimer diffuses through the now permeable membrane of dead cells and binds to DNA, which was detected by the red fluorescent signal (546 nm). The LIVE/DEAD assay was analyzed with a fluorescence microscope Olympus IX71 (Olympus Optical Co., Tokyo, Japan) by multicolour imaging. After excitation at 480 nm and emission at 510 nm the fluorescent images were stored as TIFF files using a digital camera attached to a fluorescence microscope (DP 12; BX 51; Olympus, Tokyo, Japan). The recorded images were analyzed using software (Cell-F, New York, USA). The data were expressed as the mean ± SEM and the experiment was run in triplicate.

2.6. Apoptosis Assays

Apoptosis was determined by flow cytometry using Annexin V-7AAD apoptosis detection kit (Guava Technologies, Millipore Corporation) and TUNEL detection kit (Guava Technologies, Millipore Corporation), following the manufacturer’s instructions. 5637 cells were exposed to red propolis extract EtOH-H2O 50% (v/v) at concentrations of 25, 50, and 100 μg/mL for 24 h in culture media at 37°C with 5% CO2. A range of 2.0 × 104 to 1.0 × 105 treated cells (100 μL) were added to 100 μL of Guava Nexin reagent. Cells were incubated in the dark at room temperature for 20 min and samples were acquired on the flow cytometry (Guava Flow Cytometry easyCyte System; Millipore Corporation). In this assay, an Annexin V-negative and 7-AAD-positive result indicated nuclear debris; an Annexin V-positive and 7-AAD-positive result indicated late apoptotic/death cells, while an Annexin V-negative and 7-AAD-negative result indicated live healthy cells and Annexin V-positive and 7-AAD-negative result indicated the presence of early apoptotic cells. The results were reported as the percentage of cells in each apoptotic phase (early and late) and the normal CHO-K1 cell line was used as selectivity control in this test.

For TUNEL assay 5637 cells were subjected to cells fixation procedure with 50 μL of 4% (w/v) paraformaldehyde in PBS for 60 min at 4°C and then with 200 μL of ice-cold 70% (v/v) ethanol at −20°C for at least 18 h. For staining procedure, 1.5 × 104 to 1.0 × 105 of fixed cells was washed twice and was added to 25 μL of DNA Labeling Mix for 60 minutes at 37°C. At the end of the incubation time, cells were centrifuged and suspended in 50 μL of the Anti-BrdU Staining Mix. Cells were incubated in the dark at room temperature for 30 min and samples were acquired on the flow cytometry (Guava Flow Cytometry easyCyte System; Millipore Corporation). In this assay, terminal deoxynucleotidyl transferase (TdT) catalyzes the incorporation of BrdU residues into the fragmenting nuclear DNA of apoptotic cells at the 3′-hydroxyl ends by nicked-end labeling. TRITC-conjugated anti-BrdU antibody binds to the incorporated BrdU residues, labeling the mid- to late-stage apoptotic cells.

2.7. Quantitative Real-Time PCR (qRT-PCR)

The gene expression profiles of apoptotic and oxidative stress-related genes were investigated by qRT-PCR. Cells were added to 6-well flat bottom plates at a density of 2 × 105 per well and grown at 37°C in a humidified atmosphere of 5% CO2, 95% air for 24 h. The cells were then treated with the red propolis extract EtOH-H2O 50% (v/v) at concentrations of 25, 50, and 100 μg/mL for 24 h. Total RNA extraction, cDNA synthesis, and qRT-PCR were conducted as previously described [19]. Briefly, RNA samples were isolated using TRIzol reagent (Invitrogen, USA) and samples were DNase-treated with a DNA-free kit (Ambion, USA) following the manufacturer’s protocol. First-strand cDNA synthesis was performed with 700 ng of RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, UK) according to the manufacturer’s protocol. Real-time PCR reactions were run on a Stratagene Mx3005P Real-Time PCR System (Agilent Technologies, USA) using SYBR Green PCR Master Mix (Applied Biosystems, UK) and the primers described in Table 1.

GeneSequence 5′-3′


2.8. Migration Assay

The ability of cells to migrate in monolayer cultures was assessed by a scratch-wound assay [20]. Confluent 5637-cell cultures in 6-well flat bottom plates were scraped with a p200 pipet tip to create a wide cell-free zone with a straight wound edge. Cells were grown in media with 25 and 50 μg/mL of red propolis EtOH-H2O extract for 24 h. The edge of the wound was marked at the bottom of the plate with a fine gauge hypodermic needle as a migration reference point. The distance and quantity of cell migration into the cell-free zone were evaluated on a digital camera attached to an inverted microscope for 12 h (DP 12; BX 51; Olympus, Tokyo, Japan). The recorded images were analysed using software (Cell-F, New York, USA). The data were expressed as the mean ± SEM and the experiment was run in triplicate.

2.9. Data Analysis

Data sets were analyzed using one-way or two-way ANOVA followed by a Tukey test for multiple comparisons, except for Bax/Bcl-2 ratio that was analyzed using Student -test. Significance was considered at in all analyses. Data were expressed as mean ± SEM.

3. Results

3.1. Chemical Characterization of Red Propolis Extract (Mass Analysis)

Due to environmental conditions, the chemical composition of propolis extracts may differ. As reported in a previous work, high-resolution direct-infusion mass spectrometry (HR-DIMS) was used for chemical characterization of the red propolis extract [14]. The main components were maintained as follows: m/z 257.0764 (liquiritigenin); 269.0769 (formononetin); 271.0921 (medicarpin); 285.0718 (biochanin A); 523.1641 (retusapurpurin B) (Figure 1). Exact mass, fragmentation pathway, and isotopic ratio were used for confirmation.

3.2. Red Propolis Inhibited Cell Proliferation and Increased 5637-Cell Death

The result showed that red propolis extract significantly decreased 5637-cell viability in vitro in a dose-dependent manner (Figure 2(a)). The cell growth inhibition following red propolis treatment was over 50% from 100 μg/mL in 24 hours. EtOH-H2O vehicle alone showed no cytotoxicity or antiproliferative activity at 24 h of treatment. The in vitro cytotoxic activity of red propolis extract showed an IC50 value of 95 μg/mL in 24 h of treatment. BRP treatment also inhibited proliferation in CHO-K1 cell line at 24 h of treatment, displaying no selectivity between normal and cancer cells in terms of in vitro growth inhibition (Figure 2(a)).

LIVE/DEAD assay showed an increase in cell death (red fluorescence) after red propolis treatments compared to the control group (Figure 2(b)). Additionally, a reduction in cell number can clearly be observed at concentrations of 100 μg/mL (Figure 2(b)(D)). EtOH-H2O vehicle alone treatment promoted cell death similar to that observed in the control group (data not shown).

3.3. Red Propolis Induced Apoptosis on 5637 Cells

The results indicated that red propolis is capable of inducing early apoptosis at concentrations of 50 and 100 μg/mL (55.8% and 63.9%, resp.) when compared to the control group () (Figure 3); however no apoptosis difference is observed between these two concentrations (). The concentration of 25 μg/mL was not effective () in inducing early apoptosis, presenting levels of apoptosis similar to untreated control cells (29.9 and 6.7%, resp.). The red propolis extract induced a higher percentage of late apoptosis/dead at 100 μg/mL concentration (31.1%) compared to the control (). At the 25 and 50 μg/mL concentrations the percentage of late apoptotic/dead cells was 5.1% and 14.6%, respectively, similar to that observed in the untreated control group (). Exposure of the 5637 cells to EtOH-H2O vehicle alone had no effect in apoptosis induction (data not shown). BRP treatment was not able to induce apoptosis in CHO-K1 cell line at 25 and 50 μg/mL. The percentage of apoptotic cells was 11% and 15.4% for 25 and 50 μg/mL, respectively, which is not different from untreated control group () (data not shown). Early and late apoptotic levels together at 100 μg/mL were 47% in CHO-K1 cells. Interestingly, 51% of CHO-K1 normal cells remained alive after 100 μg/mL BRP treatment but only 8% of 5637 tumoral cells remained alive after the same treatment. This result may indicate that BRP displays selectivity between normal and cancer cells in terms of in vitro apoptosis induction (Figure 3(b)).

TUNEL staining assay was performed to better elucidate the mid- to late-stage apoptosis of 5637 cells induced by red propolis, once that 7AAD staining does not differentiate between late-stage apoptoses from another cell death types. Figure 4 demonstrates that red propolis presented a tendency to increase late apoptosis inducement; however no differences () on late apoptosis rates were observed between control group and red propolis treatment at 25, 50, and 100 μg/mL in bladder cancer cells (Figure 4(b)).

3.4. Red Propolis Changes Apoptotic Gene Expression Profile on 5637 Cells

The expression levels of pro- and antiapoptotic genes (Bax, Bcl-2, AIF, Endo G, caspase-3, caspase-8, caspase-9, and p53) in 5637 cells were evaluated by qRT-PCR. As shown in Figure 4, the expression of Bax was bell-shaped, with 25 μg/mL treatment showing the higher fold induction (Figure 5(a)). However, Bcl-2 in 5637 cells was also increased after 25 and 50 μg/mL treatments when compared to the control (), showing 1.5- and 2-fold increase in mRNA expression, respectively (Figure 5(b)). Interestingly, no effect in mRNA expression levels was observed after 100 μg/mL treatment in 5637 cells when compared to the control (), showing that red propolis extract may trigger a negative feedback. However, the Bax/Bcl-2 ratio increased in 5637 cells after 100 μg/mL BRP treatment (Figure 5(c)), compared to that observed in untreated cells and 25 and 50 μg/mL treated cells ().

Apoptosis-inducing factor (AIF) mRNA expression was found to be significantly upregulated in 25 and 50 μg/mL red propolis treated cells () compared to no treated control cells and to 100 μg/mL treated cells (Figure 6(a)). No differences were observed between the controls 25 and 50 μg/mL of red propolis treatments in Endo G gene expression (Figure 6(b)). However, both Endo G and AIF mRNA levels were significantly lower () in the 100 μg/mL treatment compared to the control.

Red propolis also induced changes in the mRNA levels of caspase-9, caspase-8, caspase-3, and p53 in 5637 cells (Figure 7). Initiator caspase-9 and p53 gene were significantly upregulated () by 50 μg/mL treatment compared to control cells and other concentrations treatments (Figures 7(a) and 7(b)). Additionally, caspase-3, caspase-8, and caspase-9 were downregulated by 100 μg/mL treatment compared to no treated and to 25 and 50 μg/mL treated cells () (Figures 7(b)7(d)).

3.5. Red Propolis Increased Gene Expression of Antioxidant Enzymes

The gene expression profiles of the following enzymes were investigated in this study as follows: catalase (CAT), Cu/Zn superoxide dismutase (Cu/Zn-SOD), manganese superoxide dismutase (Mn-SOD), glutathione-S-transferase (GST), and thioredoxin reductase-1 (TRX). Red propolis showed a tendency to increased CAT, Cu/Zn-SOD, and Mn-SOD mRNA levels significantly () in cells exposed to 50 and 100 μg/mL compared to the controls (Figures 8(a), 8(d), and 8(e)); however there was no difference in CAT mRNA expression between 50 and 100 μg/mL treatments (Figure 8(d)). No difference between the control and 25 μg/mL treatment was observed for these genes expression levels. Moreover, the GST, TRX, and GLUT mRNA expression patterns were investigated and no differences between treated and untreated cells were observed (Figures 8(b), 8(c), and 8(f)), but treated cells presented a dose-dependent tendency to increased expression levels in TRX and GST genes.

3.6. Red Propolis Inhibits Migration of Urothelial Carcinoma

Migration of 5637 cells was significantly inhibited by 24 h of red propolis treatment. As shown in Figure 9, cellular migration was controlled in time-dependent by red propolis ethanolic extract. The width of the scratch-wound healing was inhibited by up to 20% and 30% at 8 and 24 h of incubation, respectively, in both concentrations of red propolis tested (Figures 9(a) and 9(b)). The number of cell migration to the scratch-wound healing was also smaller when cells were treated with BRP compared to those who were not treated (Figures 9(a) and 9(c)). Furthermore, inhibition of 5637 migrations occurred at lower concentrations (25 and 50 μg/mL) than the aforementioned IC50 concentrations by MTT assay.

4. Discussion

Natural products continue to be an invaluable resource of anticancer drug discovery [5]. The prospect of using natural products to create more selective and effective cancer treatment is a reality and propolis and its compounds possess strong antitumor potential [15, 21]. In the present study we evaluated for the first time the effect of Brazilian red propolis ethanolic extract on bladder cancer cellular model. Our in vitro data demonstrated that red propolis treatment above 50 μg/mL resulted in morphological changes, significant antiproliferative effect, and cytotoxic effect in bladder cancer cell line. Interestingly, our results have also shown that lower concentrations of red propolis treatment (25 and 50 μg/mL) are able to significantly decrease bladder cancer cells migration in vitro. These data indicate a strong effectiveness of the BRP extract against bladder cancer cell line.

Apoptosis induction is one of the mechanisms proposed for the anticancer therapeutic effects of propolis [22, 23]. Apoptosis is a well-characterized type of programmed cell death (PCD) and is considered as a highly regulated process that allows a cell to self-degrade in order to eliminate an unwanted or dysfunctional cell [24]. Conventional anticancer treatments, such as chemotherapy and radiotherapy, kill tumor cells primarily by the induction of apoptosis or apoptosis-like PCD [24, 25]. In this study we demonstrate by flow cytometry that red propolis might be an important apoptosis inductor in bladder cancer cells, showing an increase in both early and late apoptosis stages in vitro. More than that, the mechanism of apoptosis induced by BRP seems to be dependent on the concentration of the propolis extract.

A single family of proteases, the caspases, has long been considered as the pivotal executioner of all programmed cell deaths [25]. When activated, the caspases cleave a series of substrates, activate DNAses, and orchestrate cell death [26]. However, there are evidences that apoptosis can occur independently of caspases activity [27]. Apoptosis-like PCD is a programmed cell death that shows a less compact/complete chromatin condensation than in apoptosis and most of the published forms of caspase-independent apoptosis fall into this class of PCD [25]. More than that, one of the main characteristics of PCD is the fragmentation of nuclear DNA [27]. Apoptosis-inducing factor (AIF) is a flavoprotein that resides in the mitochondrial intermembrane space [28]. Upon induction of apoptosis, AIF is translocated from the mitochondria to the nucleus and it causes chromatin condensation and large-scale DNA fragmentation without caspases activation [2830]. Herein, ethanol extract of red propolis does not induce significant caspases expression activities. On the other hand, the AIF gene expression profile in the 5637-cell line increased after BRP treatment and an increase of DNA fragmentation was observed after 24 h of BRP treatment. The apoptosis gene expression data from our experiments confirmed the results of cytotoxicity and apoptosis assays, showing that BRP extract may induce apoptosis or apoptosis-like PCD in 5637 cells and that this may occur by activation of different apoptosis pathways.

The positive effect of propolis anticancer therapy is seen in its ability to initiate apoptosis in cancer cells through both the intrinsic and extrinsic pathway [22, 3135]. The intrinsic apoptotic pathway is mediated by the mitochondria and is mainly controlled by the balance and interactions between pro- and antiapoptotic members of the Bcl-2 family proteins, which regulate the permeability of the mitochondrial membrane [26]. It has been proposed that the ratio between Bcl-2 and Bax genes is more important in the regulation of apoptosis than the level of each Bcl-2 family protein alone [36] and the ratio of death and survival signals sensed by the Bcl-2 family proteins determines whether the cell will live or die [26, 37, 38]. Although both Bax and Bcl-2 genes have shown an increase in expression profile after treatment with BRP in this study, the Bax/Bcl-2 ratio in the 5637-cell line strongly increased after 100 μg/mL of BRP treatment, suggesting that Bax and Bcl-2 may be involved in the apoptotic events associated with the cytotoxic effects of BRP. More than that, our study also showed an increase in p53 gene expression after treatment with BRP extract. It is well known that p53 contributes to apoptosis induction mostly by its transcription-dependent effects. However, it has been shown that p53 can also induce cell death via direct activation of Bcl-2, Bcl-XL, and Bax [3941]. These data support our speculation that Brazilian red propolis may trigger apoptosis or apoptosis-like PCD induction through p53, Bax, and Bcl-2 activation.

The established role of antioxidant enzymes against cancer is in the prevention of oxidative DNA damage and reactive oxygen species (ROS) formation [42, 43]. It has been shown that propolis has the ability to scavenge the free radicals in rats [44]. Oxidative stress can trigger endoplasmic reticulum (ER) stress [45] and ER stress is able to induce apoptosis without involvement of caspases [46]. Moreover, the regulation of ER membrane permeability by Bcl-2 proteins could be an important molecular mechanism of ER stress-induced apoptosis [30]. It has been shown that an ethanolic red propolis extract induces MCF-7 cell apoptosis mediated by ER stress-related signaling [13]. As shown here, BRP treatment increased the mRNA levels of the antioxidant enzymes CAT, Cu/Zn-SOD, TRx, GST, and Mn-SOD in a bladder cancer cell line. We have shown previously that hydroalcoholic extract obtained from red propolis presented high polyphenol content, important DPPH scavenging ability, and SOD-like and CAT-like activities [14]. Although further work needs to be carried out, the increased levels of the antioxidant enzymes observed in the present study might reflect the response of cells towards programmed death mediated by ER stress-related signaling.

In conclusion, our findings indicate that Brazilian red propolis induces cytotoxicity on superficial bladder cancer cells in vitro and this effect may be due to a caspase-independent apoptosis or apoptosis-like PCD. Additionally, these results are insightful for the antitumor effect of BRP and we speculate that red propolis may represent a source of therapeutic agents for bladder cancer.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This work was supported by the Brazilian funding agencies: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS).


  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at: Publisher Site | Google Scholar
  2. M. Garcia, A. Jemal, E. M. Ward et al., Global Cancer Facts & Figures, American Cancer Society, Atlanta, Ga, USA, 2007.
  3. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007. View at: Publisher Site | Google Scholar
  4. P. Vuorelaa, M. Leinonenb, P. Saikkuc et al., “Natural products in the process of finding new drug candidates,” Current Medicinal Chemistry, vol. 11, no. 11, pp. 1375–1389, 2004. View at: Publisher Site | Google Scholar
  5. L. Pan, H. Chai, and A. D. Kinghorn, “The continuing search for antitumor agents from higher plants,” Phytochemistry Letters, vol. 3, no. 1, pp. 1–8, 2010. View at: Publisher Site | Google Scholar
  6. A. Daugsch, C. S. Moraes, P. Fort, and Y. K. Park, “Brazilian red propolis—chemical composition and botanical origin,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 435–441, 2008. View at: Publisher Site | Google Scholar
  7. A. A. Righi, G. Negri, and A. Salatino, “Comparative chemistry of propolis from eight brazilian localities,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 267878, 14 pages, 2013. View at: Publisher Site | Google Scholar
  8. S. M. Alencar, T. L. Oldoni, M. L. Castro et al., “Chemical composition and biological activity of a new type of Brazilian propolis: red propolis,” Journal of Ethnopharmacology, vol. 113, no. 2, pp. 278–283, 2007. View at: Publisher Site | Google Scholar
  9. B. Trusheva, M. Popova, V. Bankova et al., “Bioactive constituents of Brazilian red propolis,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 249–254, 2006. View at: Publisher Site | Google Scholar
  10. S. Awale, F. Li, H. Onozuka, H. Esumi, Y. Tezuka, and S. Kadota, “Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition,” Bioorganic and Medicinal Chemistry, vol. 16, no. 1, pp. 181–189, 2008. View at: Publisher Site | Google Scholar
  11. F. Li, S. Awale, Y. Tezuka, and S. Kadota, “Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship,” Bioorganic and Medicinal Chemistry, vol. 16, no. 10, pp. 5434–5440, 2008. View at: Publisher Site | Google Scholar
  12. C. A. Dornelas, F. V. Fechine-Jamacaru, I. L. Albuquerque et al., “Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats,” Acta Cirurgica Brasileira, vol. 27, no. 8, pp. 529–536, 2012. View at: Publisher Site | Google Scholar
  13. T. Kamiya, H. Nishihara, H. Hara, and T. Adachi, “Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress,” Journal of Agricultural and Food Chemistry, vol. 60, no. 44, pp. 11065–11070, 2012. View at: Publisher Site | Google Scholar
  14. C. O. da Silva Frozza, C. S. C. Garcia, G. Gambato et al., “Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis,” Food and Chemical Toxicology, vol. 52, pp. 137–142, 2013. View at: Publisher Site | Google Scholar
  15. G. C.-F. Chan, K.-W. Cheung, and D. M.-Y. Sze, “The immunomodulatory and anticancer properties of propolis,” Clinical Reviews in Allergy and Immunology, vol. 44, no. 3, pp. 262–273, 2013. View at: Publisher Site | Google Scholar
  16. J. B. Daleprane, T. Schmid, N. Dehne et al., “Suppression of hypoxia-inducible factor-1α contributes to the antiangiogenic activity of red propolis polyphenols in human endothelial cells,” Journal of Nutrition, vol. 142, no. 3, pp. 441–447, 2012. View at: Publisher Site | Google Scholar
  17. J. B. Daleprane, V. da Silva Freitas, A. Pacheco et al., “Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis,” Journal of Nutritional Biochemistry, vol. 23, no. 6, pp. 557–566, 2012. View at: Publisher Site | Google Scholar
  18. F. Nedel, V. F. Campos, D. Alves et al., “Substituted diaryl diselenides: cytotoxic and apoptotic effect in human colon adenocarcinoma cells,” Life Sciences, vol. 91, no. 9-10, pp. 345–352, 2012. View at: Publisher Site | Google Scholar
  19. K. R. Begnini, C. Rizzi, V. F. Campos et al., “Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro,” Applied Microbiology and Biotechnology, vol. 97, no. 4, pp. 1543–1552, 2013. View at: Publisher Site | Google Scholar
  20. C.-C. Liang, A. Y. Park, and J.-L. Guan, “In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro,” Nature Protocols, vol. 2, no. 2, pp. 329–333, 2007. View at: Publisher Site | Google Scholar
  21. D. Sawicka, H. Car, M. H. Borawska, and J. Nikliński, “The anticancer activity of propolis,” Folia Histochemica et Cytobiologica, vol. 50, no. 1, pp. 25–37, 2012. View at: Publisher Site | Google Scholar
  22. K. Aso, S.-I. Kanno, T. Tadano, S. Satoh, and M. Ishikawa, “Inhibitory effect of propolis on the growth of human leukemia U937,” Biological and Pharmaceutical Bulletin, vol. 27, no. 5, pp. 727–730, 2004. View at: Publisher Site | Google Scholar
  23. J. H. Chen, Y. Shao, M. T. Huang, C. K. Chin, and C. T. Ho, “Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells,” Cancer Letters, vol. 108, no. 2, pp. 211–214, 1996. View at: Publisher Site | Google Scholar
  24. C. Vangestel, C. van de Wiele, G. Mees, and M. Peeters, “Forcing cancer cells to commit suicide,” Cancer Biotherapy and Radiopharmaceuticals, vol. 24, no. 4, pp. 395–407, 2009. View at: Publisher Site | Google Scholar
  25. M. Leist and M. Jäättelä, “Four deaths and a funeral: from caspases to alternative mechanisms,” Nature Reviews Molecular Cell Biology, vol. 2, no. 8, pp. 589–598, 2001. View at: Publisher Site | Google Scholar
  26. R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. View at: Publisher Site | Google Scholar
  27. G. van Loo, P. Schotte, M. van Gurp et al., “Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation,” Cell Death and Differentiation, vol. 8, no. 12, pp. 1136–1142, 2001. View at: Publisher Site | Google Scholar
  28. S. A. Susin, H. K. Lorenzo, N. Zamzami et al., “Molecular characterization of mitochodrial apoptosis-inducing factor,” Nature, vol. 397, no. 6718, pp. 441–446, 1999. View at: Publisher Site | Google Scholar
  29. Q. Wang, X.-L. Zheng, L. Yang et al., “Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells,” Journal of Experimental & Clinical Cancer Research, vol. 29, article 159, 2010. View at: Publisher Site | Google Scholar
  30. X. Wang, K. E. Olberding, C. White, and C. Li, “Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis,” Cell Death & Differentiation, vol. 18, no. 1, pp. 38–47, 2011. View at: Publisher Site | Google Scholar
  31. A. Almasan and A. Ashkenazi, “Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy,” Cytokine and Growth Factor Reviews, vol. 14, no. 3-4, pp. 337–348, 2003. View at: Publisher Site | Google Scholar
  32. A. Ashkenazi, R. C. Pai, S. Fong et al., “Safety and antitumor activity of recombinant soluble Apo2 ligand,” The Journal of Clinical Investigation, vol. 104, no. 2, pp. 155–162, 1999. View at: Publisher Site | Google Scholar
  33. N. Oršolić, A. H. Knežević, L. Šver, S. Terzić, and I. Bašić, “Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 307–315, 2004. View at: Publisher Site | Google Scholar
  34. N. Orsolic and I. Basic, “Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 265–273, 2003. View at: Publisher Site | Google Scholar
  35. E. Szliszka, Z. P. Czuba, M. Domino, B. Mazur, G. Zydowicz, and W. Krol, “Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells,” Molecules, vol. 14, no. 2, pp. 738–754, 2009. View at: Publisher Site | Google Scholar
  36. T. F. Gajewski and C. B. Thompson, “Apoptosis meets signal transduction: elimination of a BAD influence,” Cell, vol. 87, no. 4, pp. 589–592, 1996. View at: Publisher Site | Google Scholar
  37. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at: Publisher Site | Google Scholar
  38. A. Strasser, L. O'Connor, and V. M. Dixit, “Apoptosis signaling,” Annual Review of Biochemistry, vol. 69, pp. 217–245, 2000. View at: Publisher Site | Google Scholar
  39. W. Chaabane, S. D. User, M. El-Gazzah et al., “Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer,” Archivum Immunologiae et Therapiae Experimentalis, vol. 61, no. 1, pp. 43–58, 2013. View at: Publisher Site | Google Scholar
  40. J. I. Leu, P. Dumont, M. Hafey, M. E. Murphy, and D. L. George, “Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex,” Nature Cell Biology, vol. 6, no. 5, pp. 443–450, 2004. View at: Publisher Site | Google Scholar
  41. U. M. Moll, N. Marchenko, and X.-K. Zhang, “p53 and Nur77/TR3—transcription factors that directly target mitochondria for cell death induction,” Oncogene, vol. 25, no. 34, pp. 4725–4743, 2006. View at: Publisher Site | Google Scholar
  42. J. M. Matés, J. A. Segura, F. J. Alonso, and J. Márquez, “Oxidative stress in apoptosis and cancer: an update,” Archives of Toxicology, vol. 86, no. 11, pp. 1649–1665, 2012. View at: Publisher Site | Google Scholar
  43. M. A. Khan, M. Tania, D. Z. Zhang, and H. C. Chen, “Antioxidant enzymes and cancer,” Chinese Journal of Cancer Research, vol. 22, no. 2, pp. 87–92, 2010. View at: Publisher Site | Google Scholar
  44. H. U. Fuliang, H. R. Hepburn, H. Xuan, M. Chen, S. Daya, and S. E. Radloff, “Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus,” Pharmacological Research, vol. 51, no. 2, pp. 147–152, 2005. View at: Publisher Site | Google Scholar
  45. D. Ron, “Hyperhomocysteinemia and function of the endoplasmic reticulum,” Journal of Clinical Investigation, vol. 107, no. 10, pp. 1221–1222, 2001. View at: Publisher Site | Google Scholar
  46. W. Ding, L. Yang, M. Zhang, and Y. Gu, “Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells,” Biochemical and Biophysical Research Communications, vol. 418, no. 3, pp. 451–456, 2012. View at: Publisher Site | Google Scholar

Copyright © 2014 Karine Rech Begnini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.